Testing results need disease context
The same genomic finding may mean different things in different cancers. Test platform, sample source and report interpretation matter.
Patients should keep complete pathology, molecular testing and treatment records.
Availability and indication must be confirmed
A drug appearing in public information does not mean it is suitable or accessible for a specific patient.
Cross-border second opinions usually require complete records before feasible options can be discussed.